On Wednesday 21 September we held our Annual Life Sciences Conference looking at Digital Health in the EU.
Digital Health technology is only just beginning to demonstrate its true potential in terms of offering personalized health care, better diagnosis, and greater quality of treatment to citizens across the world. The EU has been a good example of this exciting growth, with the European Digital Health market expected to approach a value of approximately €46 billion by the end of 2022. Meanwhile, the merging of health-related services and technology can create new challenges and issues requiring careful management, and the EU regulatory landscape continues to evolve in order to keep up with the rapid pace of innovation in this space.
During this webinar, we looked at three key areas relevant to businesses operating in or seeking to enter the EU digital health market.
Topics & Speakers:
Accessing the EU Digital Health Market: Key Regulatory Issues - James Gallagher, Partner, Mason Hayes & Curran LLP
Digital Health and the European Health Data Space - Brian Johnston, Partner, Mason Hayes & Curran LLP
Recent IP Case Developments - Gerry Kelly, Partner & Head of Intellectual Property, Mason Hayes & Curran LLP
This event was chaired by Eimear O'Brien, Senior Associate, Mason Hayes & Curran LLP.